Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

USA Rare Earth stock jumps 16% as Trump’s Project Vault plan puts rare earths back on the tape

USA Rare Earth stock jumps 16% as Trump’s Project Vault plan puts rare earths back on the tape

USA Rare Earth shares surged 16% to $25.64 midday Tuesday after President Trump announced “Project Vault,” a $12 billion plan to stockpile critical minerals. The initiative includes a $10 billion Ex-Im Bank loan and $2 billion from private investors. Commodities traders Hartree, Traxys, and Mercuria will handle procurement. Other rare earth stocks also rose sharply.
BigBear.ai (BBAI) stock price rises, but a Feb. 18 dilution vote is driving the chatter

BigBear.ai (BBAI) stock price rises, but a Feb. 18 dilution vote is driving the chatter

BigBear.ai Holdings shares rose 1.6% to $4.86 by midday Tuesday, trading between $4.70 and $5.02 on volume over 41 million. Shareholders will vote February 18 on doubling authorized common stock to 1 billion shares, with online ballots due February 17. The company recently converted $125 million in notes to equity and announced new AI customs partnerships.
DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next

DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next

DaVita shares rose nearly 20% to $132.98 after the company projected 2026 adjusted earnings per share of $13.60–$15.00, above analyst estimates. Fourth-quarter adjusted EPS reached $3.40 on revenue of $3.62 billion, both topping forecasts. The company cited higher reimbursement rates and a seasonal boost from flu vaccines. DaVita flagged a $40 million hit in 2026 from expiring ACA subsidies.
Transocean stock rises as oil rebounds; BTIG lifts target ahead of earnings (RIG)

Transocean stock rises as oil rebounds; BTIG lifts target ahead of earnings (RIG)

Transocean shares rose 1.2% to $4.88 in midday New York trading Tuesday, tracking a rebound in oil prices after Monday’s drop. BTIG raised its price target on the stock to $6, citing increased rig contracting. Transocean’s fourth-quarter results and fleet update are due Feb. 19 after the close. Traders await U.S. oil inventory data Wednesday.
Novo Nordisk warns 2026 sales could fall — and the Wegovy pill isn’t saving the mood yet

Novo Nordisk warns 2026 sales could fall — and the Wegovy pill isn’t saving the mood yet

Novo Nordisk forecast 2026 adjusted sales and operating profit will fall 5%–13% at constant exchange rates, citing pricing pressure and competition. U.S.-listed shares dropped about 12% after the outlook. The company reported 2025 sales up 10% to 309.1 billion Danish crowns and operating profit up 6%. Early U.S. uptake of its Wegovy pill was noted, but patent expiries and lower realized prices remain concerns.
Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Thomson Reuters shares fell 15.8% in Toronto Tuesday after National Bankshares cut its price target from C$300 to C$190, though it kept an outperform rating. The stock hit a 12-month low at C$124.13 before rebounding slightly. Sector peers RELX and Wolters Kluwer also dropped sharply as investors sold off AI-linked software and data stocks. Elevated trading volume followed ahead of Thomson Reuters’ Feb. 5 earnings report.
5 IBM-Heavy ETFs to Watch as Mainframe Hits 20-Year High and the Stock Whipsaws

5 IBM-Heavy ETFs to Watch as Mainframe Hits 20-Year High and the Stock Whipsaws

IBM shares fell about 7% Tuesday despite a 12% fourth-quarter revenue jump to $19.7 billion and raised analyst targets from Bank of America and Bernstein. The drop hit ETFs heavily weighted with IBM, including First Trust NASDAQ Technology Dividend Index Fund and FT Vest Technology Dividend Target Income ETF. IBM cited strong mainframe sales but warned infrastructure revenue may decline in 2026.
Costco pulls ‘no preservatives’ rotisserie chicken signs after additives lawsuit

Costco pulls ‘no preservatives’ rotisserie chicken signs after additives lawsuit

Costco removed “no preservatives” claims from its rotisserie chicken signs and online listings after two California consumers filed a proposed class-action lawsuit alleging the chicken contains sodium phosphate and carrageenan. The suit seeks to represent U.S. buyers, with a California subclass. Costco says the additives are for moisture and texture, not preservation. The complaint was filed Jan. 22 in federal court in San Diego.
Robinhood (HOOD) stock slips again as bitcoin stays weak; UK ISA rollout and earnings next week in focus

Robinhood (HOOD) stock slips again as bitcoin stays weak; UK ISA rollout and earnings next week in focus

Robinhood shares fell 1.2% to $88.87 Tuesday as crypto-linked stocks tracked bitcoin’s 1.1% drop. The company launched a tax-sheltered stocks & shares ISA in the UK, offering a 2% cash bonus and access to 5,000 U.S.-listed stocks. Investors await Robinhood’s Feb. 10 earnings for signs of trading volume trends and new products. Prediction-market activity faces uncertainty after the U.S. football season ends.
Bitmine Immersion stock slides as $10.7 billion crypto stash keeps Ethereum bet in focus

Bitmine Immersion stock slides as $10.7 billion crypto stash keeps Ethereum bet in focus

Bitmine Immersion Technologies shares fell 1.9% to $22.37 after ether dropped 4.8% Tuesday. The company holds 4.29 million ether, 193 bitcoin, $586 million in cash, and equity stakes in two firms. Bitmine staked 2.9 million ether and estimates $374 million in annual rewards. Traders await the firm’s validator-network launch set for Q1 2026.
Pfizer stock drops on obesity-drug data and 2026 outlook — what investors watch next

Pfizer stock drops on obesity-drug data and 2026 outlook — what investors watch next

Pfizer shares fell 3.4% to $25.76 early Tuesday after quarterly results and new Phase 2b obesity drug data. The company reported adjusted Q4 earnings of 66 cents per share on $17.56 billion revenue, both above analyst estimates. Pfizer reaffirmed its 2026 outlook and does not plan share buybacks this year. COVID-19 product sales continued to decline sharply.
1 46 47 48 49 50 882

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop